Disentangling Human Tolerance and Resistance Against HIV

PLoS Biology

Volumn 12, Issue 9, 2014, Pages

  Regoes, Roland R ^a   McLaren, Paul J ^b,c,d   Battegay, Manuel ^e   Bernasconi, Enos ^f   Calmy, Alexandra ^g   Günthard, Huldrych F ^h   Hoffmann, Matthias ⁱ   Rauch, Andri ^j   Telenti, Amalio ^c   Fellay, Jacques ^b,d  

^a ETH ZURICH   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁱ CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^j UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HLA B ANTIGEN; CCR5 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; HETEROZYGOTE; HLA B GENE; HOMOZYGOSITY; HOMOZYGOTE; HOST RESISTANCE; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; ALLELE; COHORT ANALYSIS; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INNATE IMMUNITY; MIDDLE AGED; PATHOLOGY; SEX DIFFERENCE; T LYMPHOCYTE; VIROLOGY;

ADULT; AGE FACTORS; ALLELES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOME, HUMAN; HETEROZYGOTE; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HOMOZYGOTE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; SEX FACTORS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 84912546321     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001951     Document Type: Article

References (52)

1. Simms EL, (2000) Defining tolerance as a norm of reaction. Evolutionary Ecology 14: 563–570.
2. Boots M, (2008) Fight or learn to live with the consequences? Trends Ecol Evol (Amst) 23: 248–250.
3. Boots M, Best A, Miller MR, White A, (2009) The role of ecological feedbacks in the evolution of host defence: what does theory tell us? Philos Trans R Soc Lond, B, Biol Sci 364: 27–36.
4. Read AF, Graham AL, Råberg L, (2008) Animal defenses against infectious agents: is damage control more important than pathogen control. PLoS Biol 6: e4.
5. Schneider DS, Ayres JS, (2008) Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol 8: 889–895.
6. Råberg L, Graham AL, Read AF, (2009) Decomposing health: tolerance and resistance to parasites in animals. Philos Trans R Soc Lond, B, Biol Sci 364: 37–49.
7. Little TJ, Shuker DM, Colegrave N, Day T, Graham AL, (2010) The coevolution of virulence: tolerance in perspective. PLoS Pathog 6: e1001006.
8. Ayres JS, Schneider DS, (2012) Tolerance of infections. Annu Rev Immunol 30: 271–294.
9. Chakrabarti LA, (2004) The paradox of simian immunodeficiency virus infection in sooty mangabeys: active viral replication without disease progression. Front Biosci 9: 521–539.
10. Roy BA, Kirchner JW, (2000) Evolutionary dynamics of pathogen resistance and tolerance. Evolution 54: 51–63.
11. Restif O, Koella JC, (2003) Shared control of epidemiological traits in a coevolutionary model of host-parasite interactions. Am Nat 161: 827–836.
12. Schafer J, (1971) Tolerance to plant disease. Annual Review of Phytopathology 9: 235–252.
13. Medzhitov R, Schneider DS, Soares MP, (2012) Disease tolerance as a defense strategy. Science 335: 936–941.
14. Rausher MD, (2001) Co-evolution and plant resistance to natural enemies. Nature 411: 857–864.
15. Miller MR, White A, Boots M, (2006) The evolution of parasites in response to tolerance in their hosts: the good, the bad, and apparent commensalism. Evolution 60: 945–956.
16. Vale PF, Fenton A, Brown SP, (2014) Limiting damage during infection: lessons from infection tolerance for novel therapeutics. PLoS Biol 12: e1001769.
17. Råberg L, Sim D, Read AF, (2007) Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318: 812–814.
18. Oliver TH, Leather SR, Cook JM, (2009) Tolerance traits and the stability of mutualism. Oikos 118: 346–352.
19. Ayres JS, Schneider DS, (2008) A signaling protease required for melanization in Drosophila affects resistance and tolerance of infections. PLoS Biol 6: 2764–2773.
20. Sternberg ED, Lefvre T, Li J, de Castillejo CLF, Li H, et al. (2012) Food plant derived disease tolerance and resistance in a natural buttery-plant-parasite interactions. Evolution 66: 3367–3376.
21. Günthard H, Opravil M, Ledergerber B, Olsson K, Vogt M, et al. (1993) Prognostic value of various pattern in CD4-lymphocyte count in 420 asymptomatic HIV-1-infected patients. Deutsche Medizinsche Wochenschrift 118: 737–745.
22. Phillips AN, Lee CA, Elford J, Janossy G, Timms A, et al. (1991) Serial lymphocyte-CD4 counts and development of AIDS. Lancet 337: 389–392.
23. Müller V, Ledergerber B, Perrin L, Klimkait T, Furrer H, et al. (2006) Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS 20: 889–894.
24. Tiffin P, Inouye BD, (2000) Measuring tolerance to herbivory: accuracy and precision of estimates made using natural versus imposed damage. Evolution 54: 1024–1029.
25. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, et al. (2006) Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296: 1498–1506.
26. Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger SE, et al. (2011) Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 121: 2391–2400.
27. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, et al. (2009) Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119: 3556–3572.
28. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, et al. (2009) Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 119: 3544–3555.
29. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, et al. (1998) Sex differences in HIV-1 viral load and progression to AIDS. Lancet 352: 1510–1514.
30. Goulder PJR, Watkins DI, (2008) Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8: 619–630.
31. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, et al. (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944–947.
32. Thomas R, Apps R, Qi Y, Gao X, Male V, et al. (2009) HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 41: 1290–1294.
33. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, et al. (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472: 495–498.
34. Berger EA, Murphy PM, Farber JM, (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657–700.
35. Pinheiro JC, Bates DM (2000) Linear mixed-effects models: basic concepts and examples. New York: Springer.
36. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, et al. (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748–1752.
37. Tang J, Costello C, Keet IP, Rivers C, Leblanc S, et al. (1999) HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 15: 317–324.
38. Tebit DM, Arts EJ, (2011) Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis 11: 45–56.
39. Scherrer AU, Ledergerber B, von Wyl V, Böni J, Yerly S, et al. (2011) Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clin Infect Dis 53: 1143–1152.
40. von Wyl V, Kouyos RD, Yerly S, Böni J, Shah C, et al. (2011) The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 204: 1095–1103.
41. Alizon S, Magnus C, (2012) Modelling the course of an HIV infection: insights from ecology and evolution. Viruses 4: 1984–2013.
42. Paiardini M, Müller-Trutwin M, (2013) HIV-associated chronic immune activation. Immunol Rev 254: 78–101.
43. Haldane J, (1949) Disease and evolution. Ric Sci Suppl A 19: 6876.
44. Allison AC, (1954) Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J 1: 290–294.
45. Hill AV, (1998) The immunogenetics of human infectious diseases. Annu Rev Immunol 16: 593–617.
46. Schmid-Hempel P (2011) Evolutionary parasitology: the integrated study of infections, immunology, ecology, and genetics, Table 10.4. Oxford Biology. Oxford, UK: Oxford University Press. Available: http://books.google.ch/books?id=OiyYhChj7GwC.
47. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, et al. (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690–695.
48. Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Günthard HF, et al. (2010) Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 39: 1179–1189.
49. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, et al. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5: e1000791.
50. Nakagawa S, Schielzeth H, (2013) A general and simple method for obtaining r2 from generalized linear mixed-effects models. Methods in Ecology and Evolution 4: 133–142.
51. R Core Team (2013) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Available: http://www.R-project.org.
52. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904–909.